Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04155619 · ClinicalTrials.gov registry record · NA
Using Early Time Restricted Feeding and Timed Light Therapy to Improve Glycemic Control in Adults With Type 2 Diabetes
A NA study of Diabetes Mellitus, Type 2 and Time Restricted Feeding, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 344
- Enrollment target
- 1
- Study location
NCT04155619 is a NA study of Diabetes Mellitus, Type 2 and Time Restricted Feeding that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 344 participants, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04155619, a NA study of Diabetes Mellitus, Type 2 and Time Restricted Feeding, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 344 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test whether eating earlier in the day and/or timed light therapy can improve blood sugar in people with type 2 diabetes. This study will also test whether these treatments improve other aspects of health, including the circadian (biological) clock, sleep, weight, body composition, cardiovascular health, quality of life, and mood.
Conditions Studied
Interventions
- BEHAVIORAL No change in meal timing
- BEHAVIORAL No change in light exposure
- BEHAVIORAL Early Time-Restricted Feeding
- BEHAVIORAL Timed Light Therapy
Study Locations (1)
Alabama
- University of Alabama at Birmingham; Birmingham Veterans Affairs Medical Center - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2021-04-26 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04155619
The ClinicalTrials.gov registry entry for NCT04155619 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 344 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (92% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 4 interventions - of which No change in meal timing is the first listed.
NCT04155619 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT04155619 about?
NCT04155619 is a clinical study titled "Using Early Time Restricted Feeding and Timed Light Therapy to Improve Glycemic Control in Adults With Type 2 Diabetes". The purpose of this study is to test whether eating earlier in the day and/or timed light therapy can improve blood sugar in people with type 2 diabetes. This study will also test whether these treatments improve other aspects of health, including the circadian (biological) clock, sleep, weight, bod...
What is the current status of trial NCT04155619?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 344 participants. The study started on 2021-04-26. Estimated completion is 2026-08.
What conditions does trial NCT04155619 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Time Restricted Feeding, Light; Therapy, Complications.
What interventions are being tested in trial NCT04155619?
The interventions under investigation include: No change in meal timing (BEHAVIORAL), No change in light exposure (BEHAVIORAL), Early Time-Restricted Feeding (BEHAVIORAL), Timed Light Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04155619?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04155619 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.